Zobrazeno 1 - 10
of 2 676
pro vyhledávání: '"Blum JL"'
Autor:
Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mtelli@stanford.edu., Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA., Jones JM; Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA., Andersen J; Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA., Mina LA; Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Brig R; Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA., Danso M; Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA., Yuan Y; Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hopkins JF; Foundation Medicine, Inc., Cambridge, MA, USA., Albacker LA; Foundation Medicine, Inc., Cambridge, MA, USA., Abbattista A; Clinical Statistics, Pfizer Oncology, Milan, Italy., Noonan K; Clinical Oncology, Pfizer Inc., Groton, CT, USA., Mata M; Pfizer Inc., La Jolla, CA, USA., Laird AD; Pfizer Inc., South San Franciso, CA, USA., Blum JL; Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Sep; Vol. 31 (5), pp. 886-897. Date of Electronic Publication: 2024 Jun 13.
Publikováno v:
Open Access Emergency Medicine, Vol Volume 10, Pp 53-59 (2018)
Edward C Jauch,1 David Y Huang,2 Allison J Gardner,3 Julie L Blum3 1Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC, USA; 2Department of Neurology, Division of Stroke and Vascular Neurology, University of North
Externí odkaz:
https://doaj.org/article/9675bd8711bd4142b70d6a18b45b5c9b
Autor:
Geyer CE Jr; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA., Blum JL; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology Research, Dallas, TX., Yothers G; NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA., Asmar L; USOR, McKesson Specialty Health, The Woodlands, TX., Flynn PJ; Minnesota Community Oncology Research Consortium (MSORC), Stone Lake, MI., Robert NJ; Ontada, Irving, TX., Hopkins JO; Novant Health (Forsyth Medical) Cancer Institute, Southeast Clinical Oncology Research (SCOR) NCORP, Winston Salem, NC., O'Shaughnessy JA; Baylor University Medical Center, Texas Oncology, US Oncology Research, Dallas, TX., Rastogi P; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; UPMC Magee-Womens Hospital, Pittsburgh, PA., Puhalla SL; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA., Hilton CJ; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; Allegheny Health Network, Pittsburgh, PA., Dang CT; Memorial Sloan Kettering Cancer Center, West Harrison, NY., Gómez HL; National Institute of Neoplastic Diseases, Lima, Peru., Vukelja SJ; US Oncology Tyler Cancer Center, Tyler, TX., Lyss AP; Heartland Cancer Research NCORP-Missouri Baptist Medical Center, St Louis, MO., Paul D; USOR, McKesson Specialty Health, The Woodlands, TX., Brufsky AM; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; UPMC Magee-Womens Hospital, Pittsburgh, PA., Colangelo LH; NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA., Swain SM; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC., Mamounas EP; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; Orlando Health Cancer Institute, Orlando, FL., Wolmark N; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 20; Vol. 42 (12), pp. 1344-1349. Date of Electronic Publication: 2024 Feb 09.
Autor:
Raja A; Division of Environmental Medicine, New York University School of Medicine, New York, NY, USA., Costa P; Division of Environmental Medicine, New York University School of Medicine, New York, NY, USA., Blum JL; Division of Environmental Medicine, New York University School of Medicine, New York, NY, USA; Product Safety Labs, Dayton, NJ, USA., Doherty-Lyons S; Division of Environmental Medicine, New York University School of Medicine, New York, NY, USA., Igbo JK; Department of Biological Oceanography, Nigerian Institute for Oceanography and Marine Research, Lagos, Nigeria., Meltzer G; Departments of Epidemiology and Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, USA., Orem W; United States Geological Survey, Reston, VA, USA., McCawley M; Department of Occupational & Environmental Health Sciences, School of Public Health, West Virginia University, South Morgantown, WV, USA., Zelikoff JT; Division of Environmental Medicine, New York University School of Medicine, New York, NY, USA. Electronic address: Judith.Zelikoff@nyulangone.org.
Publikováno v:
Reproductive toxicology (Elmsford, N.Y.) [Reprod Toxicol] 2024 Mar; Vol. 124, pp. 108533. Date of Electronic Publication: 2023 Dec 30.
Autor:
Blum JL; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. jlblum@att.net., DiCristo C; Pfizer Inc, New York, NY, USA., Gordon D; Munson Medical Center, Traverse City, MI, USA., Karuturi MS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oubre D; Ponchartrain Cancer Center, Hammond, LA, USA., Jepsen E; Novant Health Cancer Institute, Winston-Salem, NC, USA., Cuevas J; St. Louis Cancer Care, St. Louis, MO, USA., Lakhanpal S; Saint Vincent's Birmingham, Birmingham, AL, USA., Montelongo MZ; ICON plc, Blue Bell, PA, USA., Zhang Z; Pfizer Inc, La Jolla, CA, USA., Cappelleri JC; Pfizer Inc, Groton, CT, USA., Wang Y; Pfizer Inc, New York, NY, USA., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Feb; Vol. 203 (3), pp. 463-475. Date of Electronic Publication: 2023 Oct 30.
Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
Autor:
Karuturi MS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: MSKaruturi@mdanderson.org., Cappelleri JC; Pfizer Inc, Groton, CT, USA., Blum JL; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA., Patel K; CARTI Cancer Center, Little Rock, AR, USA., Telivala B; Cancer Specialists of North Florida, Jacksonville, FL, USA., McCune S; Northwest Georgia Oncology Centers, Marietta, GA, USA., Cuevas JD; St. Louis Cancer Care, St. Louis, MO, USA., Lakhanpal S; Saint Vincent's Birmingham, Birmingham, AL, USA., Montelongo MZ; ICON plc, Blue Bell, PA, USA., Wang Y; Pfizer Inc, New York, NY, USA., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rocque GB; University of Alabama at Birmingham, Birmingham, AL, USA.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2024 Jan; Vol. 15 (1), pp. 101670. Date of Electronic Publication: 2023 Dec 06.
Autor:
Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA., Jones JM; Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA., Andersen J; Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA., Blum JL; Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA., Mina LA; Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Brig R; Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA., Danso M; Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA., Yuan Y; Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA., Abbattista A; Clinical Statistics, Pfizer Oncology, Milan, Italy., Noonan K; Clinical Oncology, Pfizer Inc., Groton, CT, USA., Niyazov A; Oncology Value & Evidence, Pfizer Inc., New York, NY, USA., Chakrabarti J; Medical Oncology, Pfizer Ltd., Walton Oaks, Surrey, UK., Czibere A; Oncology Drug Development, Pfizer Inc., Cambridge, MA, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Oct 03; Vol. 28 (10), pp. 845-855.
Autor:
Blum JL; Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, Texas.
Publikováno v:
Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2023 Aug 31; Vol. 36 (6), pp. 770-771. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023).
Autor:
Corson, Stephen L.
Publikováno v:
In The Journal of Minimally Invasive Gynecology 2011 18(1):140-140
Autor:
Lyons-Darden T; NiPERA Inc., 2525 Meridian Pkwy Ste 240, Durham, NC 27713, USA., Blum JL; Product Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA., Schooley MW; Product Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA., Ellis M; Product Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA., Durando J; Product Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA., Merrill D; Product Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA., Oller AR; Oller Consulting, 722 Gaston Manor Dr, Durham, NC 27703, USA.
Publikováno v:
Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2023 Jan 07; Vol. 13 (2). Date of Electronic Publication: 2023 Jan 07.